G1 THERAPEUTICS INC's ticker is GTHX and the CUSIP is 3621LQ109. A total of 96 filers reported holding G1 THERAPEUTICS INC in Q2 2018. The put-call ratio across all filers is - and the average weighting 0.1%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q2 2019 | $2,878,000 | +110.7% | 93,882 | +14.1% | 0.01% | +75.0% |
| Q1 2019 | $1,366,000 | +4.8% | 82,282 | +20.9% | 0.00% | 0.0% |
| Q4 2018 | $1,303,000 | -65.6% | 68,053 | -6.0% | 0.00% | -55.6% |
| Q3 2018 | $3,786,000 | +23.2% | 72,398 | +2.4% | 0.01% | +12.5% |
| Q2 2018 | $3,072,000 | +20.5% | 70,694 | +2.7% | 0.01% | +14.3% |
| Q1 2018 | $2,549,000 | – | 68,812 | – | 0.01% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| INTERNATIONAL BIOTECHNOLOGY TRUST PLC | 98,482 | $1,631,000 | 0.60% |
| Opus Point Partners Management, LLC | 20,844 | $346,000 | 0.47% |
| HHLR ADVISORS, LTD. | 949,431 | $15,761,000 | 0.44% |
| Rhenman & Partners Asset Management AB | 212,169 | $3,522,000 | 0.41% |
| Virtus ETF Advisers LLC | 8,654 | $144,000 | 0.31% |
| BB BIOTECH AG | 671,925 | $11,154,000 | 0.28% |
| RA Capital Management | 363,051 | $6,027,000 | 0.26% |
| BDO Wealth Advisors, LLC | 35,234 | $585,000 | 0.17% |
| Birchview Capital, LP | 15,000 | $249,000 | 0.16% |
| SECOR Capital Advisors, LP | 37,205 | $618,000 | 0.13% |